News

Schiff Nutrition International has reported a net sales of $48.6m for the three months ended August 31, 2009, an increase when compared to $47.8m for the same period

Bolder BioTechnology (Bolder) has been awarded a $1.2m phase II Small Business Innovation Research (SBIR) grant, entitled ‘Long-Acting EPO Analog for Treating Anemia Associated with Chronic Kidney Disease,’

Merial has licensed the Clean Genome E coli developed by Scarab Genomics for commercial production of an upcoming veterinary vaccine. Reportedly, Clean Genome E coli are K-12 strains,

A new study conducted by Thomas Shea and his team of scientists demonstrated that MemoryXL previously shown to improve cognitive performance in Alzheimer’s disease on adults without dementia.

Burnham Institute for Medical Research and the Sarah W Stedman Nutrition and Metabolism Center at Duke University Medical Center have reported a new collaborative research program that will

GENova Biotherapeutics (GENova) has signed a LOI for a strategic partnership agreement with the Hospital Medical Information Department of Suncheon Cheongam University in Seoul, South Korea to gain

Pharmacyclics has reported a GAAP net loss of $5.4m, or $0.20 per share for the fourth quarter of fiscal 2009, compared to a net loss of $4.6m, or

Juvaris BioTherapeutics (Juvaris) has completed the first close on its Series B equity financing of up to $25m led by SV Life Sciences (SVLS) along with existing investor,

Regulus Therapeutics (Regulus), Alnylam and Isis Pharmaceuticals (Isis) have reported that the Japan Patent Office (JPO) has notified the Max Planck Society of its intent to grant a